KRAS and colorectal cancer: We reported a novel small RNA sequence, MIRTX, that significantly inhibits KRAS-mutant colorectal cancer cell growth in vitro and in vivo by suppressing NF-kB signaling pathways via direct inhibition of CXCR2 and PIK3R1 [15].